Skip to main content Accessibility help
×
×
Home

Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study

  • Denis Guyonnet (a1), Armelle Schlumberger (a1), Leila Mhamdi (a1), Stefan Jakob (a1) and Olivier Chassany (a2)...
Abstract

The ability of probiotics to improve bowel habits or transit time has been shown in healthy populations. Additional data are required to support the use of specific probiotics to improve gastrointestinal (GI) well-being. The present study was designed to investigate the effect of consuming fermented milk (FM) on GI well-being, digestive symptoms and health-related quality of life (HRQoL) amongst women without diagnosed GI disorders. In this double-blind, controlled, parallel-design study, subjects were randomised to ingest daily either 2 × 125 g FM containing Bifidobacterium lactis DN-173 010 and yoghurt strains or a control non-fermented dairy product for 4 weeks followed by a 4-week wash-out period. GI well-being and digestive symptoms were assessed weekly. HRQoL was measured every 4 weeks. Data were analysed using analysis of covariance and logistic regression, correcting for baseline values on the full analysis set population of 197 women (aged 18–60 years). The percentage of women reporting an improvement in their GI well-being was significantly (P < 0·01) higher in the FM group v. the control group (OR 1·69; 95 % CI 1·17, 2·45). A significantly (P < 0·05) more pronounced decrease in the composite score of digestive symptoms was observed in the FM group when comparing with the control group (least squares mean − 0·57; 95 % CI − 1·12, − 0·02). Among HRQoL dimensions, the digestive comfort score was significantly (P < 0·05) improved in the FM group compared with the control group. The present study showed that the daily consumption of a specific FM is able to improve GI well-being and digestive symptoms in adult women without GI disorders.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr Denis Guyonnet, fax +33 1 69 35 76 96, email denis.guyonnet@danone.com
References
Hide All
1 Quigley, EM & Flourie, B (2007) Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 19, 166172.
2 Spiller, P (2008) Review Article: probiotics and prebiotics in irritable bowel syndrome (IBS). Aliment Pharmacol Ther 28, 385396.
3 Camilleri, M (2006) Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 40, 264269.
4 Johansson, ML, Nobaek, S, Berggren, A, et al. (1998) Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int J Food Microbiol 42, 2938.
5 Larsen, CN, Nielsen, S, Kaestel, P, et al. (2006) Dose–response study of probiotic bacteria Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus paracasei subsp. paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60, 12841293.
6 Olivares, M, Diaz-Ropero, MA, Gomez, N, et al. (2006) Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 107, 104111.
7 Yamano, T, Iino, H, Takada, M, et al. (2006) Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1. Br J Nutr 95, 303312.
8 Matsumoto, K, Takada, T, Shimizu, K, et al. (2006) The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora 25, 3948.
9 Duez, H, Pelletier, C, Cools, S, et al. (2000) A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. J Appl Microbiol 88, 10191027.
10 Pochart, P, Marteau, P, Bouhnik, Y, et al. (1992) Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr 55, 7880.
11 Berrada, N, Lemeland, JF, Laroche, G, et al. (1991) Bifidobacterium from fermented milks: survival during gastric transit. J Dairy Sci 74, 409413.
12 Rochet, V, Rigottier-Gois, L, Ledaire, A, et al. (2008) Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product – a randomised study in healthy adults. J Mol Microbiol Biotechnol 14, 128136.
13 Agrawal, A, Houghton, LA, Morris, J, et al. (2009) Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 29, 104114.
14 Guyonnet, D, Chassany, O, Ducrotté, P, et al. (2007) Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 26, 475486.
15 Marteau, P, Cuillerier, E, Méance, S, et al. (2002) Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 16, 587593.
16 Méance, S, Cayuela, C, Raimondi, A, et al. (2003) Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis 15, 1522.
17 Méance, S, Cayuela, C, Turchet, P, et al. (2001) A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-faecal gut transit time in elderly. Microb Ecol Health Dis 13, 217222.
18 Guyatt, GH, Deyo, RA, Charlson, M, et al. (1989) Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 42, 403408.
19 Irvine, EJ, Whitehead, WE, Chey, WD, et al. (2006) Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 130, 15381551.
20 Heaton, KW, O'Donnell, LJ, Braddon, FE, et al. (1992) Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 102, 19621967.
21 Guyonnet, D, Chassany, O, Picard, C, et al. (2008) Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA©) questionnaire: development and psychometric validation. Public Health Nutr 11, 11631172.
22 Dupuy, HJ (1984) The psychological general well-being (PGWB) index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, chapter 9, pp. 170184 [Wenger, NK, Mattson, ME, Furberg, CF and Elinson, J, editors]. New York: Le Jacq Publishing.
23 Walters, SJ & Brazier, JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14, 15231532.
24 Juniper, EF, Guyatt, GH, Willan, A, et al. (1994) Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47, 8187.
25 European Medicines Agency (1998) ICH Topic E 9. Statistical Principles for Clinical Trials. Step 5. Note for guidance on statistical principles for clinical trials (CPMP/ICH/363/96). London: EMEA.
26 Goetze, O, Fruehauf, H, Pohl, D, et al. (2008) Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health. Br J Nut 100, 10771085.
27 Hernando-Harder, AC, von Bunau, R, Nadarajah, M, et al. (2008) Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation. Dig Dis Sci 53, 443450.
28 McFarland, LV & Dublin, S (2008) Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 14, 26502661.
29 Cummings, JH, Antoine, JM, Azpiroz, F, et al. (2004) PASSCLAIM – gut health and immunity. Eur J Nutr 43, Suppl. 2, II118II173.
30 van Kerkhoven, LA, Eikendal, T, Laheij, RJ, et al. (2008) Gastrointestinal symptoms are still common in a general Western population. Neth J Med 66, 1822.
31 Moayyedi, P, Ford, AC, Talley, NJ, et al. (2008) The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review. Gut (epublication ahead of print version 17 December 2008).
32 Nuovo, J, Melnikow, J & Chang, D (2002) Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 287, 28132814.
33 Altman, DG, Schulz, KF, Moher, D, et al. (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134, 663694.
34 Bouglé, D, Roland, N, Lebeurrier, F, et al. (1999) Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scand J Gastroenterol 34, 144148.
35 Kim, HJ, Camilleri, M, McKinzie, S, et al. (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17, 895904.
36 Sairanen, U, Piirainen, L, Grasten, S, et al. (2007) The effect of probiotic fermented milk and inulin on the functions and microecology of the intestine. J Dairy Res 74, 367373.
37 Bartram, HP, Scheppach, W, Gerlach, S, et al. (1994) Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects? Am J Clin Nutr 59, 428432.
38 Collado, MC, Moreno, Y, Cobo, JM, et al. (2006) Molecular detection of Bifidobacterium animalis DN-173010 in human feces during fermented milk administration. Food Res Int 39, 530535.
39 Parkes, GC, Brostoff, J, Whelan, K, et al. (2008) Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 103, 15571567.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed